

[ Mon, Sep 23rd 2024
] - WOPRAI

[ Fri, Aug 09th 2024
] - WOPRAI

[ Fri, Jul 26th 2024
] - WOPRAI

[ Tue, Jul 23rd 2024
] - WOPRAI

[ Fri, Jun 28th 2024
] - WOPRAI

[ Thu, May 02nd 2024
] - WOPRAI

[ Tue, Feb 06th 2024
] - WOPRAI

[ Wed, Jan 17th 2024
] - WOPRAI

[ Tue, Aug 01st 2023
] - WOPRAI

[ Tue, Jun 06th 2023
] - WOPRAI

[ Tue, Feb 21st 2023
] - WOPRAI
Colleen Kusy Maintained (APLS) at Buy with Decreased Target to $92 on, Sep 23rd, 2024
Colleen Kusy of Baird, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Decreased Target from $96 to $92 on, Sep 23rd, 2024.
Colleen has made no other calls on APLS in the last 4 months.
There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 4 agree with Colleen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $39 on, Friday, September 20th, 2024
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $41 on, Friday, August 9th, 2024
- Biren Amin of "Piper Sandler" Initiated at Hold and Held Target at $46 on, Friday, May 31st, 2024
- Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $48 on, Thursday, May 23rd, 2024
These are the ratings of the 6 analyists that currently disagree with Colleen
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Friday, September 20th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $57 on, Friday, September 13th, 2024
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $74 on, Friday, August 9th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 9th, 2024
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 2nd, 2024
- Akash Tewari of "Jefferies" Maintained at Strong Buy and Held Target at $80 on, Wednesday, July 31st, 2024
Contributing Sources